Pharming Group N.V.
PHAR
$12.97
-$0.12-0.92%
NASDAQ
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -32.00% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -32.00% | ||||
| Cost of Revenue | -68.56% | ||||
| Gross Profit | -22.95% | ||||
| SG&A Expenses | -10.14% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -8.33% | ||||
| Total Operating Expenses | -25.26% | ||||
| Operating Income | -262.13% | ||||
| Income Before Tax | -199.04% | ||||
| Income Tax Expenses | 186.93% | ||||
| Earnings from Continuing Operations | -197.84% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -197.84% | ||||
| EBIT | -262.13% | ||||
| EBITDA | -128.79% | ||||
| EPS Basic | -187.50% | ||||
| Normalized Basic EPS | -366.67% | ||||
| EPS Diluted | -197.22% | ||||
| Normalized Diluted EPS | -407.69% | ||||
| Average Basic Shares Outstanding | 12.41% | ||||
| Average Diluted Shares Outstanding | -1.64% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||